位元堂二零二三年年报

Contents 84Independent Auditor’s Report92Consolidated Statement ofProfit or Loss and Other Comprehensive Income95Consolidated Statement of Financial Position97Consolidated Statement of Changes in Equity99Consolidated Statement of Cash Flows101Notes to Financial Statements247Particulars of Key Properties248Five Year Financial Summary 2Corporate Information5Awards6Chairman’s Statement12Management Discussion and Analysis32Board of Directors and Senior Management36Corporate Governance Report62Report of the Directors Corporate Information Board of Directors GBS Executive Directors Mr. Tang Ching Ho,GBS, JP,Chairman and Managing DirectorMs. Tang Wai ManMs. Law Man Yee, Anita MHMH Independent Non-executive Directors Mr. Leung Wai Ho,MHMr. Siu Man Ho, SimonMr. Cho Wing MouMr. Li Ka Fai, David,MH Audit Committee MHMH Mr. Li Ka Fai, David,MH,chairmanMr. Leung Wai Ho,MHMr. Siu Man Ho, SimonMr. Cho Wing Mou Remuneration Committee MHGBS Mr. Siu Man Ho, Simon,chairmanMr. Leung Wai Ho,MHMr. Cho Wing MouMr. Tang Ching Ho,GBS, JPMs. Tang Wai Man Nomination Committee MHGBS Mr. Cho Wing Mou,chairmanMr. Leung Wai Ho,MHMr. Siu Man Ho, SimonMr. Tang Ching Ho,GBS, JPMs. Tang Wai Man Executive Committee GBS Mr. Tang Ching Ho,GBS, JP,chairmanMs. Tang Wai ManMs. Law Man Yee, Anita Authorised Representatives GBS Under Listing RulesMr. Tang Ching Ho,GBS, JPMr. Cheung Chin Wa Angus Company Secretary Mr. Cheung Chin Wa Angus Legal Advisers Reed Smith Richards Butler LLPDLA Piper Hong KongGallant Auditor Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor Principal Bankers The Bank of East Asia, LimitedChong Hing Bank LimitedChina Everbright Bank Co., Ltd.DBS Bank (Hong Kong) LimitedThe Hongkong and Shanghai Banking Corporation LimitedBank of Communications Co., Ltd., Hong Kong Branch Registered Office Clarendon House2 Church StreetHamilton HM 11Bermuda Clarendon House2 Church StreetHamilton HM 11Bermuda Head Office and Principal Place of Businessin Hong Kong Suite 3101, 31/F., Skyline Tower39 Wang Kwong RoadKowloon BayKowloonHong Kong 39313101 Corporate Information(Continued) Principal Share Registrar and Transfer Officein Bermuda MUFG Fund Services (Bermuda) Limited4th floor North Cedar House41 Cedar AvenueHamilton HM 12Bermuda MUFG Fund Services (Bermuda) Limited4th floor North Cedar House41 Cedar AvenueHamilton HM 12Bermuda Branch Share Registrar and Transfer Officein Hong Kong 1617 Tricor Secretaries Limited17/F., Far East Finance Centre16 Harcourt RoadHong Kong Board Lot 5,000 5,000 shares contact@waiyuentong.com Investor RelationsEmail: contact@waiyuentong.com http://www.wyth.net Homepagehttp://www.wyth.net Stock Code 897 897 A w a r d s( 2 0 2 2 - 2 0 2 3 ) The Nielsen Company & IQVIA& IQVIA Wai Yuen Tong Hou Tsao Powder Ranked 1st in Sales Value &Sales Volume for 9 Consecutive Years in Hong Kong9 * Based in part on data reported by Nielsen (June 2013 to May 2020) and IQVIA (June 2020 to May 2022)through its Retail Index Service for the defined Hou Cho Powder segment of Cough Remedy categoryfor the 9-year period ending May 2022, for Key Account Supermarkets, CVS and Drug Stores in HongKong (Copyright © 2020, The Nielsen Company; Copyright © 2022, IQVIA) *Nielsen(2013620205IQVIA (2020620225)202259(© 2020© 2022 IQVIA) The Nielsen Company Pearl’s Mosquitout Patch Ranked 1st in Sales Value (HK$)Share for 3 Consecutive Years in Hong Kong3 * Based in part on data reported by Nielsen (March 2019 to February 2022) through its Retail IndexService for the defined Patch segment of Mosquito Repellent category for the 3-year period endingFebruary 2022, for Total Supermarkets, CVS and Drug Stores in Hong Kong. (Copyright © 2022,NielsenIQ) *(20193– 20222)202223(© 2022) The Hong Kong Council of Social Service Wai Yuen Tong – 10 Years Plus Caring Company– 10Plus The Hong Kong Council of Social Service Luxembourg Medicine – 15 Years Plus Caring Company– 15Plus Chairman’s Statement With a century-long history and well-established reputation, “Wai Yuen Tong”has continuously strived for excellence in both Western and Chinese medicineproducts, as well as traditional Chinese medicine outpatient services for over125 years. I hereby express my heartfelt gratitude to all colleagues for theirdedication during the past challenging year in the inheritance of tradition, andcontribution to the health of people in the community. 125 Dear Shareholders, On behalf of the board of directors (the “Board” or the “Directors”) of Wai YuenTong Medicine Holdings Limited (the “Company”, together with its subsidiaries,the “Group”), I present to the shareholders the annual report for the year ended 31March 2023 (the “Year” or the “year under review”). Traditional Chinese Medicine (“TCM”) is a unique health resource in the PRC,with enormous economic potential, scientific and technological resource withoriginal advantages, excellent cultural resource and important ecologi